Elon Musk, the billionaire founder of the brain-chip startup Neuralink, announced that the first human patient had gotten an implant and was doing well.

Neurons, which the National Institutes of Health defines as cells that employ chemical and electrical signals to transfer information to and from the body throughout the brain, are the source of spikes in activity.

"The first human received an implant from @Neuralink yesterday and is recovering well," Musk tweeted on his social media platform X. "Initial results show promising neuron spike detection."

Last year, the US Food and Drug Administration granted the startup permission to carry out its first human implant experiment, marking a significant step toward its goal of assisting patients in overcoming paralysis and various neurological diseases.

Neuralink stated in September that it was approved to begin recruiting participants for the human trial.

"Initial users will be those who have lost the use of their limbs," Musk said. "Imagine if Stephen Hawking could communicate faster than a speed typist or auctioneer. That is the goal."

According to an update from Neuralink, the project employs a robot to surgically implant a brain-computer interface (BCI) implant in a part of the brain that governs the intention to move. Its primary objective is to allow people to operate a computer cursor or keyboard with just their thoughts.

According to Neuralink, the "ultra-fine" threads in the implants aid in signal transmission throughout the subjects' brains. Elon Musk said in a different post on X that Telepathy will be the name of Neuralink's initial product.

To assess the safety of the implant and surgical robot, the business is conducting a study for its wireless brain-computer interface called PRIME Study.

If the method works as planned, it will use a brain chip to integrate human and artificial intellect. Musk expressed his hope that it might aid in the treatment of neurological conditions like Alzheimer's, Parkinson's, and dementia.